Radiopharmaceuticals and Associated Consumables (NOE.0585)
Framework Overview
The Radiopharmaceuticals and Associated Consumables framework provides NHS trusts with a compliant route to radiopharmaceutical products and specialist consumables for nuclear medicine diagnostic imaging, non-imaging procedures and therapy.
The framework covers generators, radiopharmaceutical kits, therapy capsules, isotopes, ready-to-use radiopharmaceuticals and associated products and consumables, providing access to specialist suppliers for a range of nuclear medicine requirements.
Designed to support NHS nuclear medicine services, the framework provides access to products for diagnostic and therapeutic applications, with requirements covering product quality, cold-chain validation and regulatory compliance.
Additional Information
Background
The framework provides a one-stop solution to assist trusts with:
- Nuclear medicine therapy
- Nuclear medicine diagnostic non-imaging
- Nuclear medicine diagnostic imaging
Radiopharmaceuticals are a group of pharmaceutical drugs which have radioactivity. Radiopharmaceuticals are used as both diagnostic and therapeutic agents.
Radiopharmaceuticals emit radiation themselves, which is different from contrast media which absorb or alter external electromagnetism or ultrasound.
Products included cover:
• Generators
• Cold kits
• Dry kits
• Therapy capsules
• Ready to use Radiopharmaceuticals
• Generator accessories, secondary shielding, elution tools, saline, vials
Benefits
- All isotopes and kits used for the preparation of radiopharmaceuticals are licensed for use in the UK as defined in the Medicines Act 1968
- All products comply with the Medical Devices Directive 93/42/EEC
- Suppliers able to supply validated evidence of cold chain
- Assurance of supplies from quality assured suppliers
- Suppliers who are complaint with the Carriage of Dangerous Goods and the Use of Transportable Pressure Equipment Regulations 2009
- Savings against standard list prices on a huge selection of products.
Given the issues surrounding the limited market, escalating costs and the availability of molybdenum from low enriched uranium resources, NOE CPC is confident this framework will give trusts every confidence they need to be able to fulfil the requirements of any nuclear medicine department.
Lots
- Lot 1A Generators – Technetium
- Lot 1a Technetium
- Lot 1b Gallium
- Lot 1c Krypton
- Lot 1d Any other items
- Lot 2a Agents (Kits)
- Lot 2b Capsules, Isotopes and Associated items
- Lot 2c Any other items
- Lot 3 – Ready made Radiopharmaceuticals
Suppliers
- Curium Pharma UK Ltd
- GE Healthcare Limited
- Novartis Pharmaceuticals UK Limited
- Xiel Limited